YTHDC1 and prostate carcinoma: As we saw altered expression of T-STAR in prostate cancer, we used a panel of prostate cell lines to examine the protein expression of alternative splicing components, specifically Sam68, T-STAR, YTHDC1 and metadherin (Figure 3A).